Online Programs

Boston University School of Medicine Continuing Medical Education (BUSM CME) produces and accredits a variety of enduring materials, including:

  • CD-ROMs
  • Slide lecture kits
  • Monographs
  • Newsletters
  • Web-based activities
  • Teleconferences

Working with BUSM faculty, as well as outside faculty, we develop high-quality educational materials and provide extensive support to ensure compliance with ACCME guidelines. Our experienced staff is qualified to offer educational design guidance, editorial review, and responsive program coordination. Our CME application process and our detailed planning outlines make our requirements clear and easy to follow.

For a list of our current monographs and to take tests online, visit www.bucmetest.com

____________________________________________________________________

Dialysis Center

Dialysis Center Dialogues Website!

Dialysis Center Dialogues:  The KDIGO Guideline and Anemia Treatment Protocols
1 AMA PRA Category 1 Credit
1.25 Nursing Contact Hours

Target Audience
Dialysis center team members:

  • Nephrologists
  • Nephrology nurses and nurse practitioners

Learning Objectives
Upon completion of this educational activity, participants should be able to:

  • Describe the recommendations in the 2012 KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease
  • Identify dialysis patients for whom standard anemia treatment protocols can be used to effectively manage their anemia
  • List factors that can cause dialysis patients to be considered outliers for standard anemia treatment protocols

____________________________________________________________________
Alcohol, Other Drugs, and Health: Current Evidence
1.25 AMA PRA Category 1 Credit(s) ™
This is a free online newsletter, published every two months that summarizes the latest clinically relevant research on alcohol, illicit drugs, and health. Through its summaries and other features, the newsletter aims to highlight alcohol and other drug issues and provide valuable information that can be applied in clinical teaching, practice, and research.

Target Audience
The target audience is generalist clinicians, many of whom have received limited training on detecting and treating substance abuse.

After completing this activity, participants should be better able to:
Objectives

  1. State the latest research findings on alcohol, illicit drugs, and health.
  2. Incorporate the latest research findings on alcohol, illicit drugs, and health into their clinical practices, when appropriate.
  3. Recognize the importance of addressing alcohol and drug problems in primary care settings.

Expires June 30, 2013

____________________________________________________________________
Best Practices in Advanced Non-Small Cell Lung Cancer
1.00 AMA PRA Category 1 Credit(s) ™

Target Audience
Oncologists

After completing this activity, participants should be better able to:
Objectives

  1. Describe current data relating histology to treatment efficacy in NSCLC.
  2. Describe biomarkers currently used to individualize therapy for NSCLC patients.
  3. Formulate treatment plans for NSCLC patients based on tumor classification.
  4. Integrate maintenance therapy into clinical practice in an evidence-based manner.

____________________________________________________________________
Crohn’s Disease: The What, When, and Why of Treatment
2 AMA PRA Category 1 Credit(s) ™

Target Audience
Gastroenterologists, nurse practitioners, physician assistants and nurses who work with gastroenterology practices and/or treat patients with Crohn’s Disease

After completing this activity, participants should be better able to:
Objectives

  1. Articulate increased confidence in the identification of the patient with moderate to severe Crohn’s Disease and recognize which individuals are likely to benefit from use of biological therapies.
  2. Discuss the efficacy of corticosteroids, antimetabolites and biological therapies in the treatment of moderate-to-severe Crohn’s Disease.
  3. Describe the risks of corticosteroids, antimetabolites and biological therapies
  4. List the unique challenges in the treatment of patients with perianal Crohn’s disease

*Registration is free but required.

____________________________________________________________________
Cutaneous Laser (this course is currently under review)
3.5 AMA PRA Category 1 Credit(s) ™
This program is supported by an unrestricted educational grant from Candela Corporation.

____________________________________________________________________
The Ethical Oversight of Human Subjects Research Course (EO Course)
4.5 AMA PRA Category 1 Credit(s) ™
PRIM&R’s EO Course is a four-hour, online course that presents an in-depth exploration of the function and purpose of institutional review boards (IRBs) through an interactive, realistic interface.

____________________________________________________________________
Having the Difficult Conversation: Counseling Your Patients on End of Life Decisions
2 AMA PRA Category 1 Credit(s) ™
There is a large body of end of life literature which attempts to shift the discussion away from procedures toward goals of care at the end of life. This module is designed to supply the primary care practitioner with the information and the skills they need to have these discussions with their patients in the office and complete advance directives.

____________________________________________________________________
Management of Chemotherapy-Induced Nausea and Vomiting: Update on Antiemesis Guidelines
1.0 AMA PRA Category 1 Credit(s) ™

Target Audience
O)ncologists

After completing this activity, participants should be better able to:
Objectives

  1. Define the impact of CINV on patient quality of life.
  2. Categorize chemotherapy agents and combination regimens according to emetogenic risk.
  3. Review the data supporting use of individual antiemetic agents and combinations for patients on MEC and HEC regimens.
  4. Implement guideline-based strategies to ensure that every patient on chemotherapy is prescribed appropriate, evidence-based antiemetic therapy.

____________________________________________________________________
Investigator 101
This activity’s CME accreditation has expired. For more information, click here.

____________________________________________________________________
Multimodal Approaches to Chronic Pain Management
1.25 AMA PRA Category 1 Credit(s) ™

Target Audience
This activity has been designed to meet the educational needs of physiatrists involved in the management of patients in pain

After completing this activity, participants should be better able to:
Objectives

  1. Differentiate between acute and chronic pain syndromes, based on an understanding of pathophysiologic mechanisms of acute and chronic pain.
  2. Select the most appropriate strategy to manage an individuals chronic pain, which may incorporate a multimodal approach.
  3. Implement strategies that minimize risk of abuse and limit adverse effects of analgesics, including opioids.

____________________________________________________________________
Preventing Atrial Fibrillation Related Stroke with Anticoagulants:
Selecting Appropriate Therapy for Individual Patients
1 AMA PRA Category 1 Credit™
1.16 Nursing contact hour
1 Pharmacist contact hour

This one-hour enduring activity is delivered in a text-based format, discussing the most up-to-date methods of atrial fibrillation care and stroke prevention, which includes an interactive patient case and  questions.

Program Goal: To inform participants about current treatment and best practices in the use of anticoagulation therapy for preventing stroke in patients with atrial fibrillation (AF) and illustrate how to implement new therapeutic treatment options, current guidelines, and best practices.

Target Audience: Cardiologists, Hospitalists, MDs, NPs, PCPS, Physician Assistants and Pharmacists, RNs

LEARNING OBJECTIVES:
After completing this activity, the participant will demonstrate the ability to:

  1. Describe benefits of oral anticoagulants for stroke prevention in atrial fibrillation
  2. Identify the population of patients who would be at risk of stroke with atrial fibrillation
  3. Compare current and new oral anticoagulants with regards to safety, efficacy, pharmacology, cost and convenience
  4. Compare the benefits and risks of oral anticoagulant therapy for reducing the risk of stroke in atrial fibrillation patients
  5. Utilize available decision making tools to stratify the risks and benefits of anticoagulation therapy in patients with atrial fibrillation

Expiration Date: January 31st, 2014
Registration is free but required

____________________________________________________________________
Safe and Effective Opioid Prescribing for Chronic Pain *
3 AMA PRA Category 1 Credit(s) ™

____________________________________________________________________
Safe Driving and Your Older Patients
This program is currently under review.

____________________________________________________________________
STD Clinical Intensive Continuing Medical Education Module
This program is currently under review.
1 – 2.5 AMA PRA Category 1 Credit(s) ™ per section (8 sections total)
This project was made possible through funding by the Centers for Disease Control and Prevention (CDC).

____________________________________________________________________
 Strategies for Achieving Remission
1.25 CNE contact hours (Nursing Credit only)

Target Audience
Psychiatric-mental health nurses

After completing this activity, participants should be better able to:
Objectives

  1. Describe the impact of inadequate management of major depressive disorder (MDD) on patient outcomes.
  2. Incorporate updated MDD guidelines into clinical practice.
  3. Use strategies to improve patient adherence to the treatment plan.
  4. Implement effective approaches to achieving remission in patients with difficult-to-treat MDD.

____________________________________________________________________
Treatment-Resistant Focal Seizures in Adults: Current and Emerging Therapies
1 AMA PRA Category 1 Credit ™

Target Audience
Neurologists

After completing this activity, participants should be better able to:
Objectives

After completing this activity, participants should be better able to:

  1. Explain the concept of treatment resistance in patients with focal seizures.
  2. Discuss issues related to treatment strategies for focal seizures.
  3. Describe the mechanisms of action of emerging therapies for treatment-resistant focal seizures.
  4. Evaluate potential roles for emerging therapies in the care of patients with treatment-resistant focal seizures.


*Courses marked with an asterisk offer risk management credits.